The Food and Drug Administration has highlighted the potential health risks associated with using the Bayer hormonal contraeptive Yaz (ethinyl estradiol and drosperinone), pointing to a 75 percent increase in the risk of blood clots compared to other birth control pills.
The FDA’s basis for this heightened risk stems from a study which reviewed the medical history of more than 800,000 American women taking different forms of birth control between 2001 and 2007, according to USA Today.
In light of its findings, the FDA has advised women taking Yaz to contact their health care providers immediately if they develop any symptoms of blood clots. Should that becom necessary, my Virginia personal law firm colleagues and I recommend women should also consult a personal injury attorney to discuss their legal options.
Evidence continues to surface indicating potential unethical testing practices by Bayer during the approval process for Yaz. In fact, Bayer has already been cited by the FDA for making questionable claims about the effectiveness of Yaz in commercials. Did the company know the drug was dangerous before putting it on the open market? No one can say for sure, but it makes you wonder if adequate testing was done by the company before thousands of women were subjected to avoidable health risks.
To learn more, take a look at this free consumer report on the risks associated with Yaz, Yasmin, and Ocella, written by a Yaz attorney in Virginia.
PA